- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02710799
Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List
August 8, 2016 updated by: Hospital de Clinicas de Porto Alegre
Evaluation of the Effectivity of Teleconsultations for Improving the Referrals From Primary Care to Specialized Care of Patients With Chronic Endocrinological Conditions
The aim of this study is evaluate the effects of telephone teleconsultations to primary care physicians (compared to the state's referral protocol) in the referrals waiting list for endocrinological appointments.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Rio Grande do Sul state's referral list for endocrinology evaluation in specialized care is highly overloaded.
There is currently a referral protocol to select patients how should be referred.
It will be evaluated if a intervention of telephone-based teleconsultations provided by the TelessaúdeRS to the primary care physicians can provide additional benefits.
TelessaúdeRS is a telehealth program from the University of Rio Grande do Sul.
This will be evaluated in a cluster randomized clinical trial.
Study Type
Interventional
Enrollment (Actual)
3470
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90110-150
- Secretaria Estadual da Saúde
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients from counties with at least 5 endocrinology referrals waiting appointment.
- Patients referred from primary care physicians
- Patients referred because one of the protocol conditions (Diabetes Mellitus, Hypothyroidism, Hyperthyroidism, Goiter, Thyroid nodule, Obesity).
Exclusion Criteria:
- Patients from counties with more than one hundred endocrinology referrals waiting appointment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
Referrals will be evaluated through the state's protocols
|
The informations provided in the referral list will be evaluated through the state's referrals protocols.
|
|
Experimental: Intervention
Referrals will be evaluated through the state's protocols associated with telephone-based teleconsultations.
|
The informations provided in the referral list will be evaluated through the state's referrals protocols.
The teleconsultations will be performed by medical doctors, mostly family physicians, but also internists and endocrinologists.
The teleconsultations will follow a structured format to discuss some topics on the disease and access the relevant information (based on the state's protocols).
The doubts from the primary care physician will be addressed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of consultations authorized
Time Frame: 1 year
|
Number of consultations authorized after the evaluation by the control and intervention strategies.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of new referrals for endocrinology
Time Frame: 1 year
|
Total number of new referrals performed by the county.
|
1 year
|
|
Adherence to the state's protocols
Time Frame: 1 year
|
Number of new referrals for endocrinology with adequate informations according to the state's protocols.
|
1 year
|
|
Usage of TelessaúdeRS teleconsultations
Time Frame: 1 year
|
Total number of calls to TelessaúdeRS hotline (available to every primary care physician working in brazilian public health system)
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Erno Harzheim, MD, Hospital de Clinicas de Porto Alegre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
March 7, 2016
First Submitted That Met QC Criteria
March 11, 2016
First Posted (Estimate)
March 17, 2016
Study Record Updates
Last Update Posted (Estimate)
August 10, 2016
Last Update Submitted That Met QC Criteria
August 8, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 32981014.0.0000.5327
- U1111-1179-2949 (Registry Identifier: UTN)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
We plan to publish trial results in an indexed medical journal.
The results will be reported by the authors and the authorship criteria from ICMJE will be followed.
After publishing the main results of the trial the unidentified dataset will be available by contacting the authors and providing an analyses plan which will be evaluated by the study's main investigator.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.